BENSALEM, Pa., Nov. 24, 2008 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith announces that it is investigating potential claims against KV Pharmaceutical ("KV Pharmaceutical" or the "Company") (NYSE:KV-A) (NYSE:KV-B) concerning possible securities violations in relation to public statements made by the Company between February 15, 2008 and November 12, 2008. The investigation focuses on allegations that the public statements made by KV Pharmaceutical during that period failed to fully disclose or indicate, among other things, violations of Food and Drug Administration regulations and other compliance matters and management misconduct.
If you purchased KV Pharmaceutical's common stock between February 15, 2008 and November 12, 2008, or if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com.